cyclopentane has been researched along with carbobenzoxy-leucyl-leucyl-norvalinal in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hara, K; Koide, T; Kozuki, D; Omura, S; Shirotani, H; Tokunaga, F | 1 |
1 other study(ies) available for cyclopentane and carbobenzoxy-leucyl-leucyl-norvalinal
Article | Year |
---|---|
Intracellular degradation of secretion defect-type mutants of antithrombin is inhibited by proteasomal inhibitors.
Topics: Acetylcysteine; Animals; Antithrombin III; Brefeldin A; Cell Line; Cricetinae; Cyclopentanes; Cysteine Endopeptidases; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Enzyme Inhibitors; Fluorescent Antibody Technique; Golgi Apparatus; Humans; Kidney; Leupeptins; Multienzyme Complexes; Mutagenesis, Site-Directed; Protease Inhibitors; Proteasome Endopeptidase Complex; Protein Synthesis Inhibitors; Transfection | 1997 |